A phase II trial of paclitaxel and epirubicin in advanced breast cancer

Initial trials of paclitaxel and doxorubicin in advanced breast cancer yielded high response rates but significant cardiac toxicity was observed. In this phase II trial we investigated the efficacy and safety of paclitaxel combined with epirubicin. Patients with advanced breast cancer, performance s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rischin, D, Smith, J, Millward, M, Lewis, C, Boyer, M, Richardson, G, Toner, G, Gurney, H, McKendrick, J
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2000
Matèries:
Regular Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374646/
https://ncbi.nlm.nih.gov/pubmed/10945487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1306
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars